Grifols S.A.
Develops and produces plasma-derived medicines and biopharmaceutical solutions.
GRF | MC
Overview
Corporate Details
- ISIN(s):
- ES0171996087 (+4 more)
- LEI:
- 959800HSSNXWRKBK4N60
- Country:
- Spain
- Address:
- Avenida de la Generalitat 152-158, 08174 Sant Cugat del Vallès
- Website:
- https://www.grifols.com/en/home
- Sector:
- Manufacturing
Description
Grifols S.A. is a global healthcare company specializing in the development, production, and marketing of plasma-derived medicines and other biopharmaceutical solutions. As a leading producer of therapies derived from human plasma, the company addresses the needs of patients with chronic, rare, and life-threatening conditions. Its core activities encompass the entire plasma value chain, from collection to the manufacturing of essential protein therapies. In addition to its primary Biopharma division, Grifols provides a comprehensive portfolio of diagnostic solutions for transfusion medicine and clinical laboratories, as well as bio supplies for pharmaceutical and research applications. The company is committed to advancing patient health and well-being through scientific innovation and high standards of quality and safety.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-07-30 09:16 |
1H2020 Earnings results
|
English | 3.1 KB | ||
| 2020-07-30 08:46 |
Grifols presenta información correspondiente al primer semestre 2020
|
Spanish | 670.2 KB | ||
| 2020-07-20 09:57 |
[20/07/2020 8:24] Cantos, Monica:
|
English | 3.2 KB | ||
| 2020-07-20 08:12 |
Grifols ha firmado contratos de compraventa de acciones con el grupo surcoreano…
|
Spanish | 36.7 KB | ||
| 2020-06-08 18:01 |
COVID-19 Impacts
|
English | 3.1 KB | ||
| 2020-06-08 17:37 |
Impactos COVID-19
|
Spanish | 548.4 KB | ||
| 2020-05-29 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2020-05-07 17:59 |
Grifols reinforces its liquidity position to E1.7M
|
English | 3.2 KB | ||
| 2020-05-07 17:30 |
Grifols informa que en el día de hoy ha firmado con los bancos participantes en…
|
Spanish | 35.4 KB | ||
| 2020-04-21 09:03 |
1Q 2020 Earnings Release
|
English | 3.3 KB | ||
| 2020-03-30 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2020-03-27 08:42 |
Grifols informa que se han cumplido todos los trámites legales y administrativo…
|
Spanish | 39.7 KB | ||
| 2020-03-25 20:46 |
Grifols anuncia un acuerdo de colaboración con el Gobierno de EE.UU. para produ…
|
Spanish | 91.2 KB | ||
| 2020-03-04 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2020-02-27 08:25 |
Información de resultados, segundo semestre 2019
|
Spanish | 534.4 KB |
Automate Your Workflow. Get a real-time feed of all Grifols S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Grifols S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Grifols S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
